By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AdvanDx today said that it will offer Inverness Medical Innovations' BinaxNow PBP2a test in the US.

The test, which is an antibody-based rapid immunochromatographic membrane assay, received 510(k) clearance from the US Food and Drug Administration last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.